Diagnosis of Preeclampsia with Severe Features vs. Non-Severe Features
Preeclampsia is diagnosed when new-onset hypertension (≥140/90 mmHg) appears after 20 weeks of gestation, accompanied by either proteinuria OR evidence of maternal organ dysfunction or uteroplacental dysfunction—proteinuria is no longer required for diagnosis. 1, 2, 3
Core Diagnostic Criteria for Preeclampsia
Blood Pressure Requirements
- Systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg confirmed on two separate occasions at least 15 minutes apart 1, 2
- For severe hypertension (≥160/110 mmHg), confirmation should occur within 15 minutes 1
- Blood pressure must be measured with properly calibrated equipment using appropriate cuff size (large cuff if mid-upper arm circumference >33 cm) 1
Proteinuria Assessment (When Present)
- Initial screening with automated dipstick urinalysis; if ≥1+ (30 mg/dL), proceed to quantification 1, 4
- Abnormal proteinuria defined as spot urine protein/creatinine ratio ≥30 mg/mmol (0.3 mg/mg) or >0.3 g/24h 1, 2
- A negative dipstick can usually be accepted without further testing 1
Alternative Diagnostic Criteria (Without Proteinuria)
In the absence of proteinuria, preeclampsia can be diagnosed when gestational hypertension is accompanied by any of the following: 2
- Renal dysfunction: Serum creatinine ≥1.1 mg/dL or doubling of baseline 2, 3
- Hepatic dysfunction: Liver transaminases ≥2 times upper limit of normal 2, 3
- Hematological dysfunction: Thrombocytopenia <100,000/μL 2, 3
- Neurological complications: Severe headache, visual disturbances, eclampsia 2
- Pulmonary edema 2
- Uteroplacental dysfunction: Fetal growth restriction, abnormal umbilical artery Doppler, intrauterine fetal death 2
Distinguishing Severe Features from Non-Severe Features
Critical Concept
Do not attempt to clinically classify preeclampsia as "mild" versus "severe" because all cases may rapidly progress to emergencies. 1, 4 However, you must recognize severe features to guide immediate management decisions.
Preeclampsia WITH Severe Features (Any of the Following):
Blood Pressure Criteria
- Severe hypertension: Systolic BP ≥160 mmHg and/or diastolic BP ≥110 mmHg 1, 3, 5
- Inability to control BP despite using ≥3 classes of antihypertensives in appropriate doses 1
Laboratory Criteria
- Thrombocytopenia <100,000/μL 4, 3
- Progressive thrombocytopenia (worsening platelet count over time) 1, 4
- Liver transaminases >2 times upper limit of normal, especially with right upper quadrant or epigastric pain 4, 3
- Progressively abnormal liver enzymes 1, 4
- Renal insufficiency: Serum creatinine ≥1.1 mg/dL or doubling of baseline creatinine 3
- Progressive deterioration in renal function 1, 4
Clinical Criteria
- Persistent severe headache unresponsive to medication 1, 3
- Visual disturbances (scotomata, cortical blindness, retinal vasospasm) 1, 3
- Persistent epigastric or right upper quadrant pain 1, 3
- Pulmonary edema (maternal pulse oximetry <90%) 1, 3
- Eclampsia (seizures) 1
Fetal Criteria
- Reversed end-diastolic flow on umbilical artery Doppler 1
- Non-reassuring fetal status 1
- Severe fetal growth restriction 3
Preeclampsia WITHOUT Severe Features
Diagnosed when hypertension ≥140/90 mmHg with proteinuria or organ dysfunction is present, but NONE of the severe features listed above are present. 1
Essential Laboratory Monitoring Protocol
Initial Assessment at Diagnosis
- Complete blood count (hemoglobin, platelet count) 4
- Liver function tests (transaminases) 4
- Renal function tests (creatinine, uric acid) 4
- Urinalysis and protein quantification 4
- Electrolytes 1
Ongoing Monitoring Frequency
- Minimum twice weekly blood tests for hemoglobin, platelet count, liver transaminases, creatinine, and uric acid in all women with preeclampsia 1, 4
- More frequent testing (every 2 days or daily) required with clinical deterioration or severe features 4, 6
- Blood pressure monitoring every 4 hours or more frequently if severe features present 6
Management Implications Based on Classification
Preeclampsia WITHOUT Severe Features
- Outpatient management may be considered once stability is established and patient is reliable 1
- Weekly clinic visits with laboratory testing and twice weekly non-stress tests 1
- Delivery indicated at ≥37 weeks gestation 1
Preeclampsia WITH Severe Features
- Immediate hospitalization required for daily surveillance 1
- Urgent antihypertensive treatment when BP ≥160/110 mmHg using nifedipine oral, labetalol IV, or hydralazine IV 1, 6
- Magnesium sulfate for seizure prophylaxis in women with severe hypertension and neurological symptoms 1, 6
- Delivery indicated at ≥34 weeks gestation 1
- Delivery at any gestational age if progressive thrombocytopenia, progressively abnormal liver/renal function, uncontrolled severe hypertension, neurological complications, pulmonary edema, or non-reassuring fetal status 1, 4
Critical Pitfalls to Avoid
- Never use uric acid or proteinuria levels alone as indications for delivery—these should not determine timing of delivery in isolation 1, 4
- Do not wait for proteinuria to diagnose preeclampsia—approximately 25% of cases lack proteinuria 2, 3
- Do not dismiss symptoms in the absence of severe hypertension—34% of eclamptic women had maximum diastolic BP ≤100 mmHg 1
- Headache is an independent risk factor for eclampsia and epigastric pain predicts serious morbidity—these symptoms mandate immediate assessment even without severe BP elevation 1
- Inadequate monitoring frequency (failure to perform twice weekly labs) may miss rapid disease progression 1, 4
- Edema is not predictive and should not be used for diagnosis or severity assessment 1